Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

4.12
Delayed Data
As of Jan 22
 0.00 / 0.00%
Today’s Change
2.17
Today|||52-Week Range
7.67
+9.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$428.7M

Company Description

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasmsThe company was founded Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 420-3200
Investor Relations:

Employees

Shareholders

Mutual fund holders24.03%
Other institutional18.88%
Individual stakeholders15.41%

Top Executives

There are no executives to display.